跳至主要内容
临床试验/CTRI/2017/06/008766
CTRI/2017/06/008766已完成未知

A study on the influence of plasma concentrations of Adriamycin, Cyclophosphamide and Paclitaxel on clinical outcome of patients with breast cancer in a tertiary care hospital

M S Yamuna devi0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.All Ca breast patients on AC/T regimen â??diagnosed based on AJCC staging criteria, belonging to Stage I, Stage II, Stage III
  • 2.All these 3 groups with laboratory parameters between normal limit to upper limit of contraindicated values

排除标准

  • 1.Patients who were on other chemotherapy regimens previously
  • 2.Tumor beyond stage IV
  • 3.Patients with co morbid conditions like renal failure, liver failure and cardiac problems

研究者

发起方
M S Yamuna devi

相似试验

A study on the influence of blood levels of drugs... | 临床试验